COVID-19 Vaccine Trial Pauses After Adverse Reaction
COVID-19 Vaccine Trial Pauses After Adverse Reaction
The hold will likely delay trial results, and scientists say the pause is proof that safety protocols in clinical trials are working as they should.
COVID-19 Vaccine Trial Pauses After Adverse Reaction
COVID-19 Vaccine Trial Pauses After Adverse Reaction

The hold will likely delay trial results, and scientists say the pause is proof that safety protocols in clinical trials are working as they should.

The hold will likely delay trial results, and scientists say the pause is proof that safety protocols in clinical trials are working as they should.

AstraZeneca
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
AstraZeneca Downsizing R&D Staff
AstraZeneca Downsizing R&D Staff
Kate Yandell | Mar 19, 2013
Positions for 1,600 scientists at the pharmaceutical company will be eliminated globally.